𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy

✍ Scribed by Amy M. Dosoretz; Ming-Hui Chen; Sharon A. Salenius; Rudolf H. Ross; Daniel E. Dosoretz; Michael J. Katin; Constantine Mantz; Bruce M. Nakfoor; Anthony V. D'Amico

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
176 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cancer-specific mortality after radiatio
Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer
✍ Henry K. Tsai; Ming-Hui Chen; David G. McLeod; Peter R. Carroll; Jerome P. Richi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The presence of multiple determinants of aggressive cancer biology may impact prostate cancer‐specific mortality (PCSM) rates compared with fewer factors. The authors estimated PCSM after radiation therapy with short‐course androgen suppression therapy (RT+AST) or radica

Late genitourinary and gastrointestinal
Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy
✍ Michele Albert; Clare M. Tempany; Delray Schultz; Ming-Hui Chen; Robert A. Corma πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 96 KB πŸ‘ 1 views

## Abstract ## BACKGROUND This study was designed to estimate the rates of late genitourinary (GU) and rectal toxicity after magnetic resonance image (MRI)‐guided prostate brachytherapy exclusively or in conjunction with external beam radiation therapy (EBRT). ## METHODS Between November 1997 an

Different patterns of serum chromogranin
Different patterns of serum chromogranin A in patients with prostate cancer with and without undergoing hormonal therapy
✍ James T. Wu; Tsu-Lan Wu; Christine P.-Y. Chang; Kuo-Chien Tsao; Chien-Feng Sun πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 2 views

Elevated serum chromogranin A (CgA) levels have been detected in patients with prostate cancer who have developed resistance to hormonal therapy. We would like to reexamine these cases by using serial specimens to determine whether such elevated levels are also detectable in prostate cancer patients